Stony Brook researchers find unique way to screen pregnant women for substance abuse
Stony Brook researchers used a new screening tool to identify whether pregnant women coming into a New York clinic were vulnerable to substance abuse. Credit: AP/LM Otero
A screening tool developed at Stony Brook University may be helping researchers identify women who might be at a higher risk of substance use while pregnant.
The study, which reviewed medical charts and was published in the Journal of Addiction Medicine this November, found that pregnant women in the research who had less education were more likely to use tobacco. Pregnant women who were single and without a partner in the research were more likely to use cannabis.
Researchers also found the women identified as dealing with a significant stressful life event were more likely to use alcohol during their pregnancy, the study found.
To get the results, university researchers examined the medical charts of roughly 1,840 patients who used the PROMOTE Prenatal Screener in their first prenatal treatment at an outpatient clinic in New York.
Overall, what they found was that nearly 10% of patients used at least one substance while pregnant, the university said. About 7% used tobacco, roughly 3% used cannabis, and about 2.5% used alcohol.
The results, researchers say, show that a well-tested screening tool offers insights into vulnerable patients and potentially opens up an avenue for better well-being for both the mother and the child.
"I think the most important finding is that the screening for women's social and psychological vulnerabilities and substance use can help not only identify their current needs and address them but also can help address and identify women who are at risk for future substance use doing their pregnancy and prevent potentially that kind of use," said Heidi Preis, who led the study and is a Stony Brook assistant professor in the Department of Obstetrics, Gynecology and Reproductive Medicine.
Preis said there are several different types of barriers in linking vulnerable pregnant women with needed care and assistance, including sometimes the patient's fear of being scrutinized. Also, she said, some physicians may feel awkward bringing up the topics or may not have the time to ask.
Although screening for depression is more common, comprehensive screening tools like PROMOTE measure issues such as stress, social support, and substance abuse are rarer, she said. PROMOTE probes into areas such as financial stability, living conditions, stress, and mental health. It can take 2 to 3 minutes to complete or a few minutes longer for people who are asked more detailed questions about opioid use, the university said.
After receiving the results from the screening, a provider can speak with a patient to determine if any issue raised in the screener is a genuine problem. From there, they can work with the patient to decide the following action, which can involve smoking cessation or a food assistance program.
"So depending on what is identified, then the providers have resources within Stony Brook and outside of Stony Brook to refer the patient," she said.
Currently, PROMOTE is available to pregnant women at Stony Brook clinics. Researchers say they want to expand it to other institutions.
David Nemiroff, president and CEO of Harmony Healthcare Long Island, said that the Federally Qualified Health Center uses other tools to identify patients in need, including one for social determinants of health and another for depression.
In general, Nemiroff said screening tools are an important way to help people who are reluctant to speak with a medical provider.
"Any tool that will help people identify an illness or a disease and can link people to treatment for care, I think, is not a bad thing," he said.
Sherri Kaplan, vice president of Program Excellence at CN Guidance & Counseling Services, said the nonprofit also uses substance abuse disorder screening tools.
However, the PROMOTE tool can be a salient way to engage with pregnant women in a medical setting who are not necessarily seeking out treatment for substance abuse, she said.
"They're going because they're pregnant," she said. "What a great way to try to engage them and start that conversation in a nonbehavioral health clinic setting."
"They're catching them at a different time," she added.
A screening tool developed at Stony Brook University may be helping researchers identify women who might be at a higher risk of substance use while pregnant.
The study, which reviewed medical charts and was published in the Journal of Addiction Medicine this November, found that pregnant women in the research who had less education were more likely to use tobacco. Pregnant women who were single and without a partner in the research were more likely to use cannabis.
Researchers also found the women identified as dealing with a significant stressful life event were more likely to use alcohol during their pregnancy, the study found.
To get the results, university researchers examined the medical charts of roughly 1,840 patients who used the PROMOTE Prenatal Screener in their first prenatal treatment at an outpatient clinic in New York.
Overall, what they found was that nearly 10% of patients used at least one substance while pregnant, the university said. About 7% used tobacco, roughly 3% used cannabis, and about 2.5% used alcohol.
The results, researchers say, show that a well-tested screening tool offers insights into vulnerable patients and potentially opens up an avenue for better well-being for both the mother and the child.
"I think the most important finding is that the screening for women's social and psychological vulnerabilities and substance use can help not only identify their current needs and address them but also can help address and identify women who are at risk for future substance use doing their pregnancy and prevent potentially that kind of use," said Heidi Preis, who led the study and is a Stony Brook assistant professor in the Department of Obstetrics, Gynecology and Reproductive Medicine.
Preis said there are several different types of barriers in linking vulnerable pregnant women with needed care and assistance, including sometimes the patient's fear of being scrutinized. Also, she said, some physicians may feel awkward bringing up the topics or may not have the time to ask.
Although screening for depression is more common, comprehensive screening tools like PROMOTE measure issues such as stress, social support, and substance abuse are rarer, she said. PROMOTE probes into areas such as financial stability, living conditions, stress, and mental health. It can take 2 to 3 minutes to complete or a few minutes longer for people who are asked more detailed questions about opioid use, the university said.
After receiving the results from the screening, a provider can speak with a patient to determine if any issue raised in the screener is a genuine problem. From there, they can work with the patient to decide the following action, which can involve smoking cessation or a food assistance program.
"So depending on what is identified, then the providers have resources within Stony Brook and outside of Stony Brook to refer the patient," she said.
Currently, PROMOTE is available to pregnant women at Stony Brook clinics. Researchers say they want to expand it to other institutions.
David Nemiroff, president and CEO of Harmony Healthcare Long Island, said that the Federally Qualified Health Center uses other tools to identify patients in need, including one for social determinants of health and another for depression.
In general, Nemiroff said screening tools are an important way to help people who are reluctant to speak with a medical provider.
"Any tool that will help people identify an illness or a disease and can link people to treatment for care, I think, is not a bad thing," he said.
Sherri Kaplan, vice president of Program Excellence at CN Guidance & Counseling Services, said the nonprofit also uses substance abuse disorder screening tools.
However, the PROMOTE tool can be a salient way to engage with pregnant women in a medical setting who are not necessarily seeking out treatment for substance abuse, she said.
"They're going because they're pregnant," she said. "What a great way to try to engage them and start that conversation in a nonbehavioral health clinic setting."
"They're catching them at a different time," she added.
Education: Howard University
Tiffany Cusaac-Smith came to Newsday in 2023 after being a race and history reporter at USA TODAY, where she wrote enterprise and spot articles examining how the past shapes the present. Previously, she worked as the race and justice reporter at the USA TODAY Network of New York, covering issues such as criminal justice reform, housing, environmental justice, health care and politics. At The Journal News/lohud.com in Westchester County, she covered Yonkers, the state's third-largest city. She also worked at The Associated Press in Atlanta.
Honors and Awards: Criminal justice reporting fellowship with the National Press Foundation; New York News Publishers Association award for distinguished investigative reporting; Contributed reporting for Best of Gannett honor; Member of Table Stakes, a program funded by the Knight-Lenfest Local News Transformation Fund and managed by the American Press Institute to transform local news.
More rain for LI ... Thanksgiving travel ... Penny trial continues ... FeedMe: Holiday pies
More rain for LI ... Thanksgiving travel ... Penny trial continues ... FeedMe: Holiday pies
